Correlation Between Cogent Biosciences and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cogent Biosciences and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cogent Biosciences and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cogent Biosciences and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Cogent Biosciences and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cogent Biosciences with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cogent Biosciences and Syndax Pharmaceuticals.
Diversification Opportunities for Cogent Biosciences and Syndax Pharmaceuticals
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Cogent and Syndax is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Cogent Biosciences and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Cogent Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cogent Biosciences are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Cogent Biosciences i.e., Cogent Biosciences and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cogent Biosciences and Syndax Pharmaceuticals
Given the investment horizon of 90 days Cogent Biosciences is expected to generate 1.77 times more return on investment than Syndax Pharmaceuticals. However, Cogent Biosciences is 1.77 times more volatile than Syndax Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 1,363 in Cogent Biosciences on November 2, 2024 and sell it today you would lose (401.00) from holding Cogent Biosciences or give up 29.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cogent Biosciences vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Cogent Biosciences |
| Syndax Pharmaceuticals |
Cogent Biosciences and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cogent Biosciences and Syndax Pharmaceuticals
The main advantage of trading using opposite Cogent Biosciences and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cogent Biosciences position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Cogent Biosciences vs. Larimar Therapeutics | Cogent Biosciences vs. Kura Oncology | Cogent Biosciences vs. Kiniksa Pharmaceuticals | Cogent Biosciences vs. Ideaya Biosciences |
| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |